Cargando…

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors

BACKGROUND: Murine leukemia virus (MLV) vector particles can be pseudotyped with a truncated variant of the human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) and selectively target gene transfer to human cells expressing both CD4 and an appropriate co-receptor. Vector transduction m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siegert, Sandra, Thaler, Sonja, Wagner, Ralf, Schnierle, Barbara S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1215470/ https://www.ncbi.nlm.nih.gov/pubmed/16156891 http://dx.doi.org/10.1186/1742-6405-2-7

Ejemplares similares

Improved Coinfection with Amphotropic Pseudotyped Retroviral Vectors
por: Wu, Yuehong, et al.
Publicado: (2009)

Murine leukemia virus (MLV) replication monitored with fluorescent proteins
por: Sliva, Katja, et al.
Publicado: (2004)

Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
por: Pellaers, Eline, et al.
Publicado: (2022)

An Optimized Protocol for Packaging Pseudotyped Integrase Defective Lentivirus
por: Sengupta, Ranjita, et al.
Publicado: (2016)

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials
por: Schultz, Anke, et al.
Publicado: (2012)

HIV-1 Entry, Inhibitors, and Resistance
por: Lobritz, Michael A., et al.
Publicado: (2010)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy
por: Koch, Peter, et al.
Publicado: (2009)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

HIV-1 Entry and Membrane Fusion Inhibitors
por: Xiao, Tianshu, et al.
Publicado: (2021)

The stability of envelope-pseudotyped lentiviral vectors
por: Dautzenberg, Iris J. C., et al.
Publicado: (2020)

Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks
por: Schultz, Anke, et al.
Publicado: (2018)

Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
por: Mitchell, Rick S, et al.
Publicado: (2004)

Cellular Attachment and Entry Factors for Chikungunya Virus
por: Schnierle, Barbara S.
Publicado: (2019)

Gene looping between the viral LTRs is a hallmark of transcriptionally active HIV-1 and Mo-MLV proviral DNA
por: Vardabasso, Chiara, et al.
Publicado: (2009)

N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
por: Kononova, A. A., et al.
Publicado: (2017)

Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy
por: El Ashkar, Sara, et al.
Publicado: (2017)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors
por: Miklík, Dalibor, et al.
Publicado: (2018)

A novel small-molecule inhibitor of HIV-1 entry
por: Heredia, Alonso, et al.
Publicado: (2015)

VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability
por: Brun, Sonia, et al.
Publicado: (2008)

Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells
por: Hematti, Peiman, et al.
Publicado: (2004)

BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements
por: El Ashkar, Sara, et al.
Publicado: (2014)

Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
por: Duvergé, Alexis, et al.
Publicado: (2020)

Analytical characteristics and comparative evaluation of Aptima HIV-1 Quant Dx assay with Ampliprep/COBAS TaqMan HIV-1 test v2.0
por: Hatzakis, Angelos., et al.
Publicado: (2016)

Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography
por: Kutner, Robert H, et al.
Publicado: (2009)

Short Communication: Potential Risk of Replication-Competent Virus in HIV-1 Env-Pseudotyped Virus Preparations
por: Bilska, Miroslawa, et al.
Publicado: (2017)

Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
por: Moore, John P
Publicado: (2006)

Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System
por: Tani, Hideki
Publicado: (2014)

Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
por: Tomás, Hélio A., et al.
Publicado: (2019)

No evidence for epitranscriptomic m(5)C modification of SARS-CoV-2, HIV and MLV viral RNA
por: Huang, Anming, et al.
Publicado: (2023)

A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects
por: Brown, Jennifer, et al.
Publicado: (2014)

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
por: Köstler, J, et al.
Publicado: (2009)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

The Gap Procedure: for the identification of phylogenetic clusters in HIV-1 sequence data
por: Vrbik, Irene, et al.
Publicado: (2015)

Infection of Female Primary Lower Genital Tract Epithelial Cells after Natural Pseudotyping of HIV-1: Possible Implications for Sexual Transmission of HIV-1
por: Tang, Yuyang, et al.
Publicado: (2014)

Regulation of ABC Drug Efflux Transporters in Human T-Cells Exposed to an HIV Pseudotype
por: Whyte-Allman, Sana-Kay, et al.
Publicado: (2021)

Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors
por: De Feo, Christopher J., et al.
Publicado: (2012)

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
por: Chen, Catherine Z., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sdhhi1bc1d540ebhbmpuvdvbbl